Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

529
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
529
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Lipid Absorption01:24

Lipid Absorption

366
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
366
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study.

Atherosclerosis·2026
Same author

Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross-Sectional Analysis From the VOLTAIRE Study.

Diabetes, obesity & metabolism·2026
Same author

Obicetrapib safety analysis: Pooled phase 3 clinical trial experience.

American journal of preventive cardiology·2026
Same author

Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular care.

The Lancet regional health. Western Pacific·2026
Same author

Design and Rationale of the pERSonalized cardIovascuLar dIsease prEvention, treatmeNt, and CarE (RESILIENCE) study.

Contemporary clinical trials·2026
Same author

CETP Inhibitors: Back With a New Target.

Circulation research·2026

Related Experiment Video

Updated: Jun 3, 2025

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.0K

Learnings from Implementation Strategies to Improve Lipid Management.

Nick S R Lan1,2,3, Ruofei Trophy Chen4, Girish Dwivedi5,6,7

  • 1Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia. nick.lan@uwa.edu.au.

Current Cardiology Reports
|January 8, 2025
PubMed
Summary

Optimizing lipid management requires multifaceted strategies targeting clinicians and patients. Implementation science can guide future research on improving cardiovascular risk reduction through better low-density lipoprotein (LDL)-cholesterol control.

Keywords:
AdherenceCardiovascular diseaseImplementationLipid managementStatin

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.0K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.9K

Area of Science:

  • Cardiovascular Medicine
  • Implementation Science
  • Health Services Research

Background:

  • Lowering low-density lipoprotein (LDL)-cholesterol is crucial for reducing cardiovascular risk.
  • Current guidelines recommend LDL-cholesterol goals, yet many high-risk patients do not achieve them or receive adequate therapy.
  • Real-world studies indicate a gap in achieving optimal lipid management and therapy intensity.

Purpose of the Study:

  • To review recent implementation strategies for optimizing lipid management in clinical practice.
  • To discuss approaches for improving patient attainment of LDL-cholesterol goals and therapy adherence.

Main Methods:

  • Review of contemporary real-world studies on lipid management implementation.
  • Analysis of clinician-level interventions, including team-based care and decision support.
  • Evaluation of patient-focused strategies for adherence and system-level approaches like EHRs and telehealth.

Main Results:

  • Multidisciplinary care, pharmacist/nurse-led interventions, and educational initiatives show promise at the clinician level.
  • Patient education, shared decision-making, and behavioral support improve adherence.
  • Electronic health records and telehealth models offer cost-effective ways to identify patients and improve access to care.

Conclusions:

  • Multifaceted strategies addressing clinician, patient, and system factors are effective for improving lipid management.
  • Future research should incorporate implementation science frameworks to assess long-term outcomes, sustainability, and scalability.
  • Understanding barriers and facilitators is key for broader application of successful strategies.